Kindler HL, Novello S, Bearz A, Ceresoli GL, et al. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial. Lancet Oncol 2022;23:540-552.
PMID: 35358455